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ntroduction. According to a topical up-to- 
z z ze  definition suggested in PRACTALL [1], 
r^r'cise-induced bronchial asthma (EIBA) is a 
sezarate variant of bronchial asthma (BA) when 
~=-sient bronchial obstruction associated with 
:~.sical activity is detected. Its occurrence in
— dren without BA is determined as “bronchial 
srasm” or “exercise-induced bronchial 
:c-striction” [2, 3]. Exercise-induced bronchial 
scasm (EIBS) is objectively determined as 10% 
■eruction of FEV1 (forced expiratory volume in
second) and more than that of the initial value 
;~er appropriate bronchial provocation test [4, 
F Although the most frequent trigger of EIBA 
s ntensive and relatively long physical activity, 
r  s disease is characterized by a multi-trigger 
rraracter of exacerbations altering the course 
:f 3A into more severe one [6]. According to 
“ ese authors in addition to physical activity 
~e following triggers of BA are: meteorological 
•actors (32,9%), acute respiratory viral infection 
-RVI) of effect of cold (22,3%), pollen (19,0%), 
j r  mal epidermis (14,4%), house dust (11,0%), 
rrd exposure to tobacco smoke (8,0%). At the 
icne  time there are certain data proving the 
“  e of a genetic component in the development 
'J 3A as a multifactorial disease [7-8]. These 
~ .estigations deal with the study of the role of 
:e etion gene polymorphism coding the activity 
:* glutathione-S-transferase for the course of BA
- children [9-10].
At the same time, it should be noted that 
: =:-iogenesis of BA phenotype has not been 
i'-died completely yet, which is evident 
* unsolved questions of diagnostics and 
':v idualized approaches to treatment. Modern 
>: entific literature available does not present 
= .^ficient evidence concerning the value of 
:enetic component, and deletions of GSTT1 
GSTM^enes in particular, and/or mutation 
:c ymorphism of eNOS gene in the formation of 
e-erase-induced bronchial spasm.
Objective of the investigation: to study the 
value of deletion (GSTT1 and GSTM1 genes) 
and mutation (eNOS gene) polymorphism in 
the formation of bronchial instability in children 
suffering from exercise-induced bronchial asthma 
in order to optimize individualized therapeutic- 
preventive recommendations.
Materials and methods. To achieve the 
purpose of the study 102 children of a school 
age suffering from BA were examined at the 
Pulmonological-allergological department of the v. 
Regional Children Clinical Hospital in Chernivtsi. 
With the aim to verify EIBA the tolerance o f  
patients to physical activity was studied, as well as 
bronchial instability was determined in response 
to graduated .running and bronchial-motor test 
with the inhalation of 200 meg of Salbutamol [11- 
12]. At the same time, the results obtained were 
presented in the following indices: bronchial 
lability index (BLI, %) and its components -  
bronchial spasm index (BSI, %) and bronchial 
dilation index (BDI, %). Provocative spirography 
test with graduated exercise was performed 
under conditions of rejection of medicines able 
to change non-specific reactivity of the bronchi 
to indirect (graduated running) bronchial spasm 
stimuli.
2 clinical groups were formed on the basis of 
examination of children. The first group (I, the 
main one) included 50 school children diagnosed 
with EIBA, and the group of comparison (II 
group) included 52 patients with BA without signs 
of exercise-induced bronchial spasm (EIBS). 
An average age of children in the I group was 
11,2±0,4 (95% confidence interval (Cl) 10,3- 
12,1) including 22 girls (44,0%) and boys -  28 
(56,0%). There were 27 rural residents (54,0%), 
and urban ones -  23 patients (46,0%). An 
average duration of the disease was 6,18±0,45 
(95% Cl 5,3-7,1). In the II clinical group there 
were 16 girls (30,8%), and 36 boys (69,3%). An 
average age of the patients in the II clinical group 
was 12,02±0,46 (95% Cl 11,1-12,9). 25 children 
were rural residents (48,1%), and urban ones -  
27 patients (51,9%). An average duration of the 
disease was 6,77±0,55 (95% Cl 5,7-7,9). The 
data available are the evidence to consider that 
by the main clinical characteristics the groups of 
comparison did not differ much, and thus they 
were comparable.
Geneticexaminationsto study polymorphism of 
GS7Tr  GSTM1 and eNOS genes were conducted
in the certified laboratory at the Department of 
Molecular Genetics and Biotechnology, Yuriy 
Fedkovych Chernivtsi National University using 
the method of polymerase-chain reaction.
The study was performed in the parallel groups 
formed according to the principle of a simple 
random sampling method “experiment-control”. 
The examinations were conducted during the 
period without attacks of the disease. Provocative 
spirography tests with graduated exercise were
performed under conditions of rejection of 
medicines able to change non-specific reactivity 
of the bronchi to direct (histamine) and indirect 
(graduated running) bronchial spasm stimuli.
Results and discussion. Considering literary 
data concerning the participation of GSTT1 and 
GSTM1 genes in realization of oxidative stress in 
the respiratory tract [13], the frequency of their 
deletion polymorphism was studied in children of 
the comparison groups (Table 1).
Table 1
Frequency of combinations of QSTT, and GSTM1 gene polymorphism in children o f the 
comparison groups
Clinical groups
N u m b e r  
o f  
patients
Distribution of GSTTj and GSTMI genotypes
_ Ti t  _ Ttdel M + T + M del Ttdel M;del
A B A B A B A B
I group 50 21 42,0 . 9 18,0 15 30,0 5 10,0
II group 52 28 53,8 . 7 13,5 15 28,8 2 3,9
P(p >0,05 >0,05 >0,05 <0,05
Note: A -  absolute number of patients; B - % percentage from the total number of patients
Therefore, deletion polymorphism of GSTT1 
and GSTM1 genes was detected in practically 
every second child suffering from BA. At the 
same time, in 1/3 of patients of the I clinical 
group (28,0%) deletions of GSTT1 gene were 
detected, and in the similar part of children 
from the group of comparison (32,7%) -  GSTM1 
gene. In addition, patients with EIBA phenotype 
presented practically three times as frequent
“zero” genotype of the genes indicated above 
(10,0% against 3,85%, P<0,05). It gives the 
ground to think that deletion in GSTT1 genes 
can influence upon the pronunciation of EIBS 
development.
Table 2 presents bronchial instability indices 
in children of the I clinical group depending on 
deletion polymorphism of GSTT1 and GSTM1 
genes.
Table 2
Bronchial instability indices in patients suffering from EIBA depending on deletion 
polymorphism of GSTT, and GSTM1 genes (P±m)
Genotype BSI, % BDI, % BII, %
GSTT+M + 21,0*2,44 10,1±2,16* 31,1±3,67
GSTTr M + 24,2±4,98 11,2±4,24* 35,4±5,64
GSTT,+Mr 18,4±0,9 21,0*2,72 39,3±2,86
GSTT,-Mr 19,4±1,7 12,8±4,92 32,1±4,83
P >0,05 - >0,05
Note: * - P<0,05 relatively to GSTT1+M1-
The presented results enable to consider 
that EIBS is the most pronounced in 
children with GSTMj+genotype, especially 
in combination with deletions of GSTT1 gene 
(GSTT1de!M + genotype,). In case patients 
with EIBA possess GS 7"M,+genotype, 
especially in combination with GSTT^+ 
(GS7Tr+Mf+genotype), the least pronounced 
bronchial motor test with Salbutamol is detected, 
that might reflect re-modulation of the respiratory
tract [14]. The afore-mentioned gives the reasons 
to consider that availability of GSTM+ genotype 
in patients with EIBA is accompanied by a 
potential risk to develop pronounced EIBS and 
weak bronchial motor reaction (according to the 
data of BDI) caused by a probable re-modulation 
of the bronchi. Table 3 presents the indices of 
bronchial hypersensitivity (BHS) and bronchial 
hyperactivity (BHA) to histamine in children of 
the comparison groups.
Table 3
Indices of hypersensitivity and hyperactivity of the bronchi in children of the comparison 
groups (M±m) ,
Spirography parameters I group II group P
PC20H, mg/ml 1,25±0,24 1,26±0,18 >0,05
PD20H, mg 0,29±0,05 0,$2±0,14 >0,05
DDC (dose-dependent curve) 2,29±0,2 1,76±0,11 =0,01
The data obtained give the grounds to suggest 
that bronchial sensitivity to histamine in the groups 
of comparison does not differ considerably, 
while their reactivity was reliably pronounced in 
children with EIBA. At the same time it should 
be noted that representatives of the I clinical
hypersensitivity (PC20H, PD20H) and hyperactivity 
(DDC) of the bronchi as well as basic spirography 
index (Tiffeneau coefficient) reflecting 
permeability of the respiratory tract. Therefore, 
the data presented enable to consider, that none 
of the indices of bronchial hypersensitivity to
group demonstrated pronounced sensitivity and 
eactivity of the bronchi to histamine inhalations 
Tiore frequently. Thus, provocative concentration 
Df histamine (PC20H) less than 0,2 mg/ml was 
bund in the patients in 23,5% of observations, 
provocative dose (PD20H) more than 0,9 mg was 
found only in 5,9% of cases, and DDC more than 
2.5 -  in 37,5%. In the group of comparison the 
requency of the given indices of hypersensitivity 
Bnd hyperactivity of the bronchi was 6,9% 
P<0,05), 20,9% (P<0,05) and 11,6% (P<0,05) 
espectively.
Table 4 presents the indices of non-specific
histamine, used as diagnostic tests in verification 
of EIBA, does not exceed information value of 
a technically simple spirography test, that is, 
Tiffeneau coefficient. In case of positive results 
of the tests mentioned above availability of EIBA 
increases in the following way: PC20H<0,2 mg/ 
ml -  on 27,0%, PD20H <0,05 mg -  on 12,0%, 
DDC >2,5 - on 26,0% and Tiffeneau coefficient 
<80,0% from the standard one -  on 35,2%. In 
case of negative results of the above mentioned 
diagnostic methods post-test probability of EIBA 
absence becomes 4,9%, 3,2%, 8,6% and 12,4% 
less respectively.
Table 4
Diagnostic value of certain spirography indices to verify EIBA
Spirography parameters
Diagnostic value, % (95% Cl) Likelihood ratio of
sensitivity specificity
Prognostic value of
positive
result
negative
resultpositive
result
negative
result
PC20H <0,2 mg/ml 23,5
(16-33)
93,0
(86-97)
77,0
(58-90)
54,9
(47-62)
3,36 0,82
PD20H <0,05 mg 26,5
(18-36)
83,7
(75-90)
61,9
(46-76)
53,2
(45-61)
1,62 0,88
DDC >2,5 37,5
(28-48)
88,4
(80-94)
76,4
(62-87)
58,6
(50-66)
3,23 0,71
Tiffeneau 
coefficient<80,0% from 
the standard
44,4
(34-55)
92,3
(85-97)
85,2
(72-94)
62,4
(54-70)
5,77 0,6
Note: PC20H -  provocative concentration o f histamine; PD20H -  provocative dose o f histamine; 
DDC -  dose-dependent curve
The use of spirography indices as risk factors 
of EIBA availability is presented in Table 5. The 
results of evaluation of clinical-epidemiological 
risk of EIBA availability considering the presented 
spirography indices enable to believe that all 
of them except PD20H can be considered as 
probable criteria. At the same time, availability of
initial bronchial obstruction in children reflecting 
^basic values of Tiffeneau coefficient is not 
lower but even increases risk indices of a time- 
consuming method to evaluate sensitivity and 
reactivity of the bronchi to histamine considering 
verification of EIBA.
Table 5
Clinical-epidemiological risk of EIBA availability depending on certain spirography 
parameters
Spirography parameters Odds ratio 
(95% Cl)
Relative risk (95% 
Cl)
Attributive risk
PC7nH <0,2 mg/ml 4,08 (1,7-10,0) 1,71 (0,8-3,8) 0,32
PD7flH <0,05 mg 1,85 (0,9-3,7) 1,32 (0,8-2,3) 0,15
DDC >2,5 4,57 (2,2-9,5) 1,84(1,01-3,3) 0,35
Tiffeneau coefficient <80,0% 
from the standard
9,57 (4,2-22,0) 2,27(1,1-4,63) 0,48
Note: PC,QH -  provocative concentration of histamine; PD ,(|H 
dose-dependent curve
-  provocative dose of histamine; DDC -
Estimation of diagnostic value of bronchial 
inflammation activity indices and probably 
markers of their hypersensitivity connected with 
this process give the ground to consider that 
in case of sufficient specificity of these tests is 
usually accompanied a considerable part of false- 
negative results limiting post-test probability of
EIBA in case of positive and negative results of 
the test. At the same time, numerous from the 
presented indices are indicative of a reliable 
although inconsiderable risk of EIBA availability 
in the patients examined.
The role of endothelial A/O-synthase is known 
to participate in the development of inflammatory
Kocesses of the respiratory tract, and eNOS 
jene refers to the production of nitrogen 
nonoxide in the early stage of inflammation 
esulting in relaxation of vessels and increasing 
heir permeability as well as promotes “efflux”
syndrome. Considering this fact to study the 
frequency of mutation polymorphism of this 
gene in the groups of comparison appears to be 
reasonable (Table 6).
Table 6
Frequency of eNOS genotypes in children of clinical groups of comparison
Clinical groups « £
Distribution of eNOS genotypes
•2  c  S GG GT TT
J5 '+H OSZ  o a. c A B A > B A B
I group 28 15 53,6
4 *
ii
t
39,3 2 7,14
II group 22 ' 10 45,5 8 36,4 4 • 18,2
P(p
>0,05
>0,05 <0,05
Note: A -  absolute number of patients; B - % percentage from the general number of patients.
The data presented give the possibility to TT occurred rhost frequently in children without
consider that mutations of eNOS (genotypes EIBS signs, giving the grounds to suggest the
GT, TTJ occur in every second child suffering effect of mutation polymorphism of eNOS gene
from bronchial asthma. Homozygous genotype on the indices of bronchial instability (Table 7).
Table 7
Indices of bronchial instability in patients suffering from EIBA depending on mutation of 
eNOS gene (P±m)
Genotype BSI, % BDI, % BII, %
[ GG 20,3±2,57 19,8±3,49 40,0±3,85
GT 20,1 ±2,49 11,7±1,23* 31,3±4,9
TT 21,5±5,5 12,0±1,3 33,5±5,5
P >0,05 - >0,05
Note: * - P<0,05 concerning GG genotype
The data mentioned are indicative of the fact 
[hat mutation of eNOS gene does not affect 
considerably EIBS pronunciation at the same 
time decreasing results of bronchial-motor tests 
with salbutamol, probably due to availability of 
3ronchial re-modulation in a child [15]. Therefore, 
analysis of genetic susceptibility of the children 
jrganism on the whole was indicative of the fact 
[hat exercise induced bronchial spasm increased 
significantly in case deletions in GSTM^ene were 
absent, and they could be partially considered
as susceptibility factors to the development of 
bronchial obstruction after physical activity. In 
patients with EIBA pronunciation of bronchial 
motor reaction after salbutamol inhalation 
decreased considerably in case they possessed 
GSTM+ genotype and/or mutations of eNOS 
gene.
The data presented above stipulated 
reasonability to study the indices of diagnostic 
value of certain genotypic peculiarities in children 
to identify EIBA (Table 8).
Table 8
Diagnostic value of certain genotypic characteristics to verify EIBA
Genotypic
characteristics
Diagnostic value, % (95% Cl) Odds ratio of
sensitivity specificity Prognostic value of positive'
result
negative
results
positive
result
negative
result
GSTTldelM + 18,0
(11-27)
86,5
(78-92)
57,1
(38-74)
51,3
(43-59)
1,33 0,95
€
GSTT +Mtdel 30,0
(21-40)
.,71,1
(61-80)
50,9
(37-64)
50,4
(42-59)
1,04 0,99 л
f
eNOS/GG 53,6
(43-64)
,54,5 
(44-64) •
54,1
(44-64)
54,0
(44-64)
1,18 0,85
eNOS/GT 39,3
(29-49)
63,3
(53-73)
51,9
(40-64)
51,2
(42-60)
1,08 0,95
Therefore, only the absence of deletions * 4. 
in GSTM1 gene of a child can be considered 
as a specific test to verify EIBA. Mutation 1 
polymorphism of eNOS gene according to 
the data above did not possess substantial 
information value to verify EIBA.
It should be noted that only absent deletions 
in GSTM1 gene increased post-test probability of 
EIBA in case of a positive result on 7,0% do not 
considerably influencing on a negative post-test 
probability. Availability of other presented above 
genotypic characteristics in children did not 
influence considerably on the post-test probability 
in case of positive and negative results of these 
tests.
Conclusion. In children suffering from 
exercise induced bronchial asthma the least 
pronunciation of bronchial motor reaction after 
salbutamol inhalation was found in children 
with GSTTj+M^ genotype and/or mutations of 
eNOS gene, that might reflect re-modeling of the 
respiratory tract and was indicative of a potential 
risk of bronchial obstruction development after 
physical activity.
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Summary. The value of deletion (GSTT1 
nd GSTM1 genes) and mutation (eNOS gene) 
olymorphism in the formation of bronchial 
istability in school children suffering from 
xercise-induced bronchial asthma was studied. 
Ixercise induced bronchial spasm was found
to be the most pronounced in children with 
GSTM + genotype especially in combinations 
with deletions of GSTT1 gene (GSTT1delM + 
genotypej, and in case patients with ElBApossess 
GS71Vlr+ genotype especially in combination with 
GSTT^+ gene (GSTT+M^genotype) the least 
pronounced bronchial motor test with salbutamol 
is found which probably reflects re-modulation 
of the respiratory tract. Mutation of eNOS gene 
does not affect considerably EIBS pronunciation 
at the same time decreasing results of bronchial- 
motor tests with salbutamol, probably due to 
availability of bronchial re-modeling in a child.
Key words: children, exercise induced 
bronchial asthma, gene polymorphism.
